This book collects the contribution of a selected number of clinical psychiatrists, interested in the clinical application of some aspects of neurobiology of anxiety. The seven chapters of the book address some issues related to the latest acquisitions of neurobiology, in particular those aspects that are related to responses to treatment - both psychological and pharmacological. Some chapters are also dedicated to the comorbidities, a rule rather than an exception when it comes to anxiety. Each author summarized the clinical importance of his work, underlining the clinical pitfalls of this new book on anxiety.
The interactive computer-generated world of virtual reality has been successful in treating phobias and other anxiety-related conditions, in part because of its distinct advantages over traditional in vivo exposure. Yet many clinicians still think of VR technology as it was in the 1990s–bulky, costly, technically difficult–with little knowledge of its evolution toward more modern, evidence-based, practice-friendly treatment. These updates, and their clinical usefulness, are the subject of Advances in Virtual Reality and Anxiety Disorders, a timely guidebook geared toward integrating up-to-date VR methods into everyday practice. Introductory material covers key virtual reality concepts, provides a brief history of VR as used in therapy for anxiety disorders, addresses the concept of presence, and explains the side effects, known as cybersickness, that affect a small percentage of clients. Chapters in the book's main section detail current techniques and review study findings for using VR in the treatment of: · Claustrophobia. · Panic disorder, agoraphobia, and driving phobia. · Acrophobia and aviophobia. · Arachnophobia. · Social phobia. · Generalized anxiety disorder and OCD. · PTSD. · Plus clinical guidelines for establishing a VR clinic. An in-depth framework for effective (and cost-effective) therapeutic innovations for entrenched problems, Advances in Virtual Reality and Anxiety Disorders will find an engaged audience among psychologists, psychiatrists, social workers, and mental health counselors.eractive
Recent years have witnessed major advances in the study of neuroscience which have increased our understanding of the relationship between cerebral processes and behavioural, cognitive and emotional disorders. This series aims to monitor important research developments in the field of biological psychiatry and their relevance to clinical practice. In recent years there has been a recognition of specific anxiety states such as panic disorder, obsessive-compulsive disorder and post-traumatic stress syndrome, involving active research into potential drug treatments. This volume provides an authoritative review of anxiety in all its clinical manifestations together with current ideas on the biological processes which are the cause of anxiety disorders. It also provides an up-to-date analysis of new drug therapies. It will be of value to psychiatrists, psychopharmacologists, psychologists, clinical neuroscientists and general physicians.
Pediatric Anxiety Disorders provides a critical, updated and comprehensive overview of anxiety disorders in children and adolescents based on the current state of empirical research. The book provides specific clinical recommendations which integrate new knowledge from neuroscience and innovative delivery formats for interventions. This is the first reference to examine anxiety diagnoses in accordance with the latest edition of the DSM-5, including childhood onset disorders, such as Separation Anxiety Disorder, Selective Mutism, Specific Phobia, Social Anxiety Disorder, Panic Disorder, Agoraphobia and Generalized Anxiety Disorder. The book assists clinicians in critically appraising the certainty of the evidence-base and the strength of clinical recommendations. - Uses the latest edition of the Diagnostic and Statistical Manual of Mental Disorders, the DSM-5 - Includes the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach in assessing guideline development - Focuses on advances in etiology, assessment and treatment - Presents new advances in our understanding of the brain behind fear and anxiety - Uses a stepped care approach to treatment
This book collects the contributions of a number of clinical psychiatrists all over the world, interested in developing basic research about anxiety and in applying it in clinical contexts. It is divided into four sections, covering general issues about anxiety (ethological and developmental ones), basic research issues on specific aspects of anxiety (bioanatomical ones, correlation with personality structure and so on), and new clinical and therapeutical proposals and hypothesis. Each author summarized the clinical importance of his work, underlining the clinical pitfalls of this publication.
Anxiety is a widespread and universal problem with significant adverse effects on mental health and quality of life. This book examines the phenomenology, psychopathology, and biological mechanisms of anxiety disorders. Over three sections, the book examines various social and clinical aspects of anxiety as well as neurobiological data and pathogenesis of anxiety disorders such as Capgras syndrome and de Clerambault’s syndrome. It also presents results of immunological and neurochemical studies of some anxiety states.
This book, the ideal following of the previous New Insights into Anxiety Disorders, collects papers of a number of clinical psychiatrists all over the world, giving their contribution to the comprehension and clinical management of anxiety disorders. Following the previously edited book on anxiety, this new one will focus on some specific clinical issues such as PTSD, psychosomatics, and complementary approaches to anxiety management themes which were not discussed in the previous book.
Anxiety disorders are amongst the most common of all mental health problems. Research in this field has exploded over recent years, yielding a wealth of new information in domains ranging from neurobiology to cultural anthropology to evidence-based treatment of specific disorders. This book offers a variety of perspectives on new developments and important controversies relevant to the theory, research, and clinical treatment of this class of disorders. Clinicians will find reviews of state-of-the-art treatments for panic disorder, social anxiety disorder, phobias, obsessive-compulsive disorder, generalized anxiety disorder, and post-traumatic stress disorder, as well as controversies over diagnostic and treatment issues. Researchers will find in-depth consideration of important selected topics, including genetics, neuroimaging, animal models, contemporary psychoanalytic theory, and the impact of stressors. This book illustrates the enormous advances that have occurred in anxiety research and describes the evolving multi-disciplinary efforts that will shape the future of the field.
In the last decade, tremendous progress has been made in understanding and addressing generalized anxiety disorder (GAD), a prevalent yet long-neglected syndrome associated with substantial functional impairment and reduced life satisfaction. This comprehensive, empirically based volume brings together leading authorities to review the breadth of current knowledge on the phenomenology, etiology, pathological mechanisms, diagnosis, and treatment of GAD. Provided are psychological and neurobiological models of the disorder that combine cutting-edge research and clinical expertise. Assessment strategies are detailed and promising intervention approaches described in depth, including cognitive-behavioral, interpersonal, psychodynamic, and pharmacological therapies. Also covered are special issues in the treatment of GAD in children, adolescents, and older adults.
Generalized Anxiety Disorder may be seen as a gateway condition from normalcy to pathology with blurred boundaries towards several concurrent disorders. This anxiety illness is responsible for psychological suffering and personal dysfunction in a considerable proportion of individuals in the general population. Since its original definition in the DSM-III (1980), the clinical and scientific interest in Generalized Anxiety Disorder has grown, becoming a challenge for researchers and practitioners nowadays. This book provides a modern viewpoint with intriguing insights on relevant topics, including historical frameworks, epidemiology, basic neurobiological sciences, clinical presentation and complexity, and major treatment options. The list of contributors include professors, researchers, PhD students, clinical psychiatrists and psychologists; they belong to different universities and training institutions and all of them possess a distinguished expertise in the specific fields of interest. Psychiatrists, physicians, psychologists, residents and undergraduate students may take advantage of this book, from both clinical and research-oriented perspectives.
